Brief: Cleo Diagnostics Seeks Trading Halt
02/11/2023 23:48
Nov 3 (Reuters) - Cleo Diagnostics COV.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON RESULTS OF
CLEO'S
FIRST CLINICAL VALIDATION STUDY FOR TRIAGE TEST
Source text for Eikon: ID:nASX2XC61s
Further company coverage: COV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CLEO Diagnostics
See all newsBrief: Cleo Diagnostics Raises A$5M
Brief: Cleo Diagnostics Seeks Trading Halt Pending Material Capital Raising Announcement
Brief: Cleo Diagnostics Says Partnership With Entityrisk
Australia's Cleo Diagnostics rises to near 2-month high on US approval for trial
Australia's Cleo Diagnostics jumps on US clinical trials for cancer blood test